<DOC>
	<DOCNO>NCT00004152</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure may improve ability detect metastatic melanoma determine extent disease . PURPOSE : Phase II trial evaluate effectiveness PET CT scan detect metastatic disease patient stage III stage IV melanoma .</brief_summary>
	<brief_title>PET CT Scans Evaluate Patients With Stage III Stage IV Melanoma</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate sensitivity , specificity , accuracy fludeoxyglucose F 18 ( FDG ) positron emission tomography ( PET ) image detect metastatic disease patient stage III IV melanoma consider operative management base currently accept diagnostic work include CT imaging . II . Determine often clinical management patient alter base FDG PET image finding addition CT scan result . OUTLINE : Patients require fast minimum 6 hour prior positron emission tomography ( PET ) imaging . Fludeoxyglucose F 18 ( FDG ) administer IV 15 minute follow 50-60 minute later whole body PET imaging . Iodinated contrast dye administer IV injection mouth follow CT image chest , abdomen , pelvis within 2 week PET image . Whole body FDG PET image CT image chest , abdomen , pelvis repeat 6 month . Initial positive PET CT image result verify base surgical and/or biopsy finding clinical follow-up . PROJECTED ACCRUAL : A total 100 patient accrue study within 2.5 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven melanoma consider operative management 1 following : Deep primary melanoma ( great 4 mm , stage IIIA ) Regional nodal disease ( stage IIIB ) Locally regionally recurrent disease extremity consider operative resection isolate limb perfusion curative intent Systemic disease consider curative resection ( stage IV ) PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception Able fast 6 hour Able lie still positron emission tomography image No second malignancy except previously treat nonmelanomatous skin cancer carcinoma situ cervix No active infection No inflammatory disease ( sarcoidosis rheumatoid arthritis ) No allergy shellfish contrast dye use CT image PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>